N-allylethenesulfonamide | 15411-32-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: N-allylethenesulfonamide
• 英文别名: N-prop-2-enylethenesulfonamide
• CAS: 15411-32-2
• 化学式: C₅H₉NO₂S
• 分子量: 147.198
• InChiKey: CHICVXSQEMYXAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-allylethenesulfonamide 在 RuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 作用下， 以 二氯甲烷 为溶剂， 反应 6.0h， 以0.46 g的产率得到2,3-dihydroisothiazole-1,1-dioxide
  参考文献：
  名称：

  Carbazole-Containing Sulfonamides as Cryptochrome Modulators

  摘要：

  本文涉及含有咔唑基磺胺衍生物及其药用可接受盐或水合物的结构式I，其中变量R1、R2、R3、R4、R5、R6、R7、A、B、C、D、E、F、G、H、a和b分别描述。还提供了包含式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、肥胖症、代谢综合征、库欣综合征和青光眼。

  公开号：

  US20130303524A1
• 作为产物：
  描述：

  2-氯乙烷磺酰氯 、 丙烯胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-allylethenesulfonamide
  参考文献：
  名称：

  Carbazole-Containing Sulfonamides as Cryptochrome Modulators

  摘要：

  本文涉及含有咔唑基磺胺衍生物及其药用可接受盐或水合物的结构式I，其中变量R1、R2、R3、R4、R5、R6、R7、A、B、C、D、E、F、G、H、a和b分别描述。还提供了包含式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、肥胖症、代谢综合征、库欣综合征和青光眼。

  公开号：

  US20130303524A1

文献信息

• Carbazole-containing sulfonamides as cryptochrome modulators
  申请人：Reset Therapeutics, Inc.

  公开号：US09265772B2

  公开（公告）日：2016-02-23

  The subject matter herein is directed to carbazole-containing sulfonamide derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R1, R2, R3, R4, R5, R6, R7, A, B, C, D, E, F, G, H, a, and b are accordingly described. Also provided are pharmaceutical compositions comprising the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, obesity, metabolic syndrome, Cushing's syndrome, and glaucoma.

  本主题涉及结构式I中含有咔唑基的磺酰胺衍生物及其药学上可接受的盐或水合物，其中变量R1、R2、R3、R4、R5、R6、R7、A、B、C、D、E、F、G、H、a和b相应地描述。还提供了包含式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，例如糖尿病、肥胖症、代谢综合征、库欣综合征和青光眼。
• CARBAZOLE-CONTAINING SULFONAMIDES AS CRYPTOCHROME MODULATORS
  申请人：RESET THERAPEUTICS, INC.

  公开号：US20160200732A1

  公开（公告）日：2016-07-14

  The subject matter herein is directed to carbazole-containing sulfonamide derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, B, C′, D, E, F, G, H′, a, and b are accordingly described. Also provided are pharmaceutical compositions comprising the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, obesity, metabolic syndrome, Cushing's syndrome, and glaucoma.

  本文的主题是针对含有咔唑基的磺酰胺衍生物及其结构式I中的药学上可接受的盐或水合物，其中变量R1、R2、R3、R4、R5、R6、R7、A、B、C'、D、E、F、G、H'、a和b分别进行描述。同时提供了包含式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、肥胖症、代谢综合征、库欣综合征和青光眼。
• Rapid, Scalable Assembly of Stereochemically Rich, Mono- and Bicyclic Acyl Sultams
  作者：Naeem Asad、Thiwanka B. Samarakoon、Qin Zang、Joanna K. Loh、Salim Javed、Paul R. Hanson

  DOI：10.1021/ol403070w

  日期：2014.1.3

  A one-pot, sequential protocol is reported that involves complementary ambiphile pairing (CAP) of a vinyl sulfonamide with a variety of unprotected amino acids via aza-Michael addition and subsequent intramolecular amidation. The method generates diverse, sp(3)-rich mono- and bicyclic acyl sultams in a highly scalable manner. Modular pairing of stereochemically rich building blocks allows quick access to all possible isomers. Extension to include one-pot, sequential 3-, 4-, and 5-multicomponent protocols is also discussed.
• Triazole-Containing Isothiazolidine 1,1-Dioxide Library Synthesis: One-Pot, Multi-Component Protocols for Small Molecular Probe Discovery
  作者：Alan Rolfe、Thomas O. Painter、Naeem Asad、Moon Young Hur、Kyu Ok Jeon、Marek Brzozowski、Sarra V. Klimberg、Patrick Porubsky、Benjamin Neuenswander、Gerald H. Lushington、Conrad Santini、Paul R. Hanson

  DOI：10.1021/co200093c

  日期：2011.9.12

  The construction of two libraries of triazole-containing isothiazolidine 1,1-dioxides is reported utilizing either a one-pot click/aza-Michael or click/OACC esterification protocol. One core dihydroisothiazole 1,1-dioxide scaffold was prepared rapidly on multigram scale via ring-closing metathesis (RCM) and was subjected to a one-pot multicomponent click/aza-Michael protocol with an array of amines and azides for the generation of a 180-member triazole-containing isothiazolidine 1,1-dioxide library. Alternatively; three daughter scaffolds were generated via the aza-Michael Of three, amino alcohols, followed by a one-pot, multicomponent dick/esterification protocol utilizing a ring-opening metathesis polymerization (ROMP)-derived coupling reagent, oligomeric alkyl carbodiimide (OACC) to generate a 41-member library of triazole-Containing isothiazole 1,1-dioxides.
• 10.1021/0l100035e
  作者：Rolfe, Alan、Samarakoon, Thiwanka B.、Hanson, Paul R.

  DOI：10.1021/0l100035e

  日期：——